Cebranopadol
- Generic Name
- Cebranopadol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H27FN2O
- CAS Number
- 863513-91-1
- Unique Ingredient Identifier
- 7GDW9S3GN3
- Background
Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.
- Associated Conditions
- -
- Associated Therapies
- -
First-In-Class Cebranopadol Moving to Phase 3 Trials
Tris Pharma launches ALLEVIATE-1 and ALLEVIATE-2 phase 3 trials for cebranopadol, a dual-NMR agonist targeting NOP and MOP receptors to reduce opioid side effects without compromising pain relief. Trials will enroll over 500 patients post-surgery, aiming for FDA approval.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath